Velleca Mark A.
SEC CIK 1706847 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BDTX | Black Diamond Therapeutics, Inc. | Pres, CEO, Dir | 121.5K | — | — | 8 | 2022-03-18 | 2025-01-30 |
Most active insiders at BDTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Raman Prakash | Dir | — | — |
| 2 | Behbahani Ali | Dir | — | — |
Velleca Mark A. made no open-market trades at BDTX in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-31 | 2025-01-30 | BDTX | Black Diamond Therapeutics, Inc. | Velleca Mark A. | Pres, CEO, Dir | A - Grant | $0.00 | +75.0K | 121.5K | +161% | $0 |
| D | 2023-09-18 | 2023-09-15 | BDTX | Black Diamond Therapeutics, Inc. | Velleca Mark A. | Pres, CEO, Dir | A - Grant | $3.60 | +5,208 | 46.5K | +13% | +$18.7K |
| 2023-06-16 | 2023-06-16 | BDTX | Black Diamond Therapeutics, Inc. | Velleca Mark A. | Dir | A - Grant | $2.10 | +8,929 | 41.3K | +28% | +$18.8K | |
| 2023-03-20 | 2023-03-16 | BDTX | Black Diamond Therapeutics, Inc. | Velleca Mark A. | Dir | A - Grant | $1.67 | +11.2K | 32.4K | +53% | +$18.8K | |
| 2022-12-19 | 2022-12-16 | BDTX | Black Diamond Therapeutics, Inc. | Velleca Mark A. | Dir | A - Grant | $1.50 | +8,424 | 21.2K | +66% | +$12.6K | |
| 2022-09-19 | 2022-09-16 | BDTX | Black Diamond Therapeutics, Inc. | Velleca Mark A. | Dir | A - Grant | $2.62 | +4,294 | 12.7K | +51% | +$11.3K | |
| 2022-06-17 | 2022-06-17 | BDTX | Black Diamond Therapeutics, Inc. | Velleca Mark A. | Dir | A - Grant | $2.03 | +5,542 | 8,439 | +191% | +$11.3K | |
| 2022-03-18 | 2022-03-18 | BDTX | Black Diamond Therapeutics, Inc. | Velleca Mark A. | Dir | A - Grant | $3.02 | +2,897 | 2,897 | New | +$8,749 |
Purchase Sale Sale after option exercise All abbreviations